Jacob Øgaard presents an update on FUJIFILM Diosynth Biotechnologies currently available, and incoming large-scale capacity and capabilities for the drug substance manufacturing of Biologics across our locations in the United States and Europe, with emphasis on HillerØd, Denmark, and Holly Springs, NC, USA sites. Jacob also covers the ability to go from small to large scale as product demand increases, and how FDB is fostering alignment across our large-scale sites at an unprecedented level in the industry. This webinar took place at the February 2024 Outsourced Pharma Capacity Update event.